The Study to Describe Symptom Control and Impact on Daily Life in Gastroesophageal Reflux Disease (GERD) Patients
NCT01200550
·
clinicaltrials.gov ↗
COMPLETED
Status
1233
Enrollment
INDUSTRY
Sponsor class
Conditions
Gastroesophageal Reflux Disease
Sponsor
AstraZeneca